Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis.
Data(s) |
01/03/2010
|
---|---|
Identificador |
http://dx.doi.org/10.1111/j.1365-2249.2009.04070.x http://www.scopus.com/inward/record.url?scp=74549136857&partnerID=8YFLogxK |
Idioma(s) |
eng |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Copland , D A , Hussain , K , Baalasubramanian , S , Hughes , T R , Morgan , B P , Xu , H , Dick , A D & Nicholson , L B 2010 , ' Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. ' Clinical and Experimental Immunology , vol 159 , no. 3 , pp. 303-314 . DOI: 10.1111/j.1365-2249.2009.04070.x |
Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2400/2403 #Immunology #/dk/atira/pure/subjectarea/asjc/2700/2723 #Immunology and Allergy |
Tipo |
article |